GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 7 filers reported holding GLAXOSMITHKLINE PLC in Q2 2024. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $268,000 | -8.5% | 6,957 | +2.3% | 0.07% | -11.5% |
| Q3 2016 | $293,000 | +2.8% | 6,803 | +3.4% | 0.08% | -34.5% |
| Q2 2016 | $285,000 | +26.7% | 6,578 | +18.5% | 0.12% | +24.0% |
| Q1 2016 | $225,000 | +0.4% | 5,553 | -0.1% | 0.10% | -2.0% |
| Q4 2015 | $224,000 | +1.4% | 5,556 | -3.3% | 0.10% | -2.0% |
| Q3 2015 | $221,000 | -17.8% | 5,747 | -1.5% | 0.10% | -9.9% |
| Q2 2015 | $269,000 | 0.0% | 5,833 | 0.0% | 0.11% | 0.0% |
| Q1 2015 | $269,000 | +8.0% | 5,833 | +0.1% | 0.11% | -0.9% |
| Q4 2014 | $249,000 | +5.1% | 5,827 | +13.2% | 0.11% | -2.6% |
| Q3 2014 | $237,000 | +1.7% | 5,147 | +18.4% | 0.12% | +10.6% |
| Q2 2014 | $233,000 | +2.6% | 4,348 | +2.5% | 0.10% | -1.9% |
| Q1 2014 | $227,000 | +10.7% | 4,243 | +10.5% | 0.11% | +14.0% |
| Q4 2013 | $205,000 | – | 3,840 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |